Moderna (NASDAQ:MRNA) stock, after a few years in the doldrums, has accomplished a major turnaround. The biotech company saw its stock soar in early pandemic days thanks to the development and commercialization of its coronavirus vaccine. It went on to become a blockbuster product. But when demand for the vaccine slipped later in the health crisis, Moderna’s earnings and stock performance suffered.
The biotech quickly took charge of the situation, cutting costs where needed and putting a focus on oncology and rare disease candidates. All of these efforts have started to brighten Moderna’s earnings reports, and investors have sat up and taken notice.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a “Double Down” signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same “Total Conviction” signal is flashing for a company 1/100th the size of Nvidia. Continue »
The stock has soared 650% this year, largely outperforming many tech giants, the stocks that have driven positive market performance in recent years. Moderna stock still may be far from its record high, but it is trading 60% above analysts’ estimates. At today’s levels, is Moderna ripe for a stock split? Let’s find out.
Image source: Getty Images.
Why do a stock split?
First, we’ll zoom in on the subject of stock splits and consider why companies decide on such moves. A stock split involves offering current shareholders additional shares, and this is done in accordance with the ratio of the split. So, in a 10-for-1 stock split, a holder of one share prior to the operation would hold 10 shares afterward. The value of the holding remains the same; so, if the stock price were $1,000 prior to the operation, it would be $100 post-split, and the shareholder in my example still would have a holding worth $1,000.
These operations don’t change anything fundamental, meaning the company’s valuation remains exactly the same. So if a stock is seen as expensive according to its price-to-earnings ratio before the split, it will remain expensive after too.
Why do companies opt for stock splits? Often, they make such a decision after a period of gains that has left the stock trading at high levels. The definition of “high” can vary greatly depending on the company and the levels reached in the past. For example, one company may choose to do a stock split if its shares reach a few hundred dollars, while another may do so when its stock reaches beyond $1,000. It’s important to note that many make the decision when a stock trades around the $1,000 level, as it may represent a psychological hurdle for investors; they might see a stock trading at this amount as pricey even if its valuation is low.
Lowering a stock price
The advantage of a stock split is that it mechanically lowers the price of each share, making the stock more accessible for a greater number of investors. Some retail investors, for example, don’t have the investing budget to pay $1,000 for one stock — but at a lower price point, they would be eager to get in on that particular company.
That said, a stock split isn’t a catalyst for stock performance, so on its own, it doesn’t make a company a good or bad investment. It’s purely mechanical and at most will make it easier for more investors to buy a particular stock.
Now, let’s get back to Moderna. Could a stock split be on the horizon? The biotech hasn’t yet done a split, so past behavior doesn’t offer us any particular clues. Moderna stock has indeed skyrocketed this year — but it isn’t anywhere near the record high it reached in early pandemic days.
So management might say that, in spite of the gain this year, Moderna remains at levels that make it accessible — and from here it could roar higher as it did in the past.
Meanwhile, investors are excited about Moderna’s personalized cancer vaccine candidate, one that delivered excellent results in a phase 3 melanoma trial, and a regulatory submission may be next. At the same time, this candidate is involved in about nine additional trials in other cancer types. Trial data and regulatory news represent potential upcoming catalysts for stock performance.
All of this suggests that Moderna may not opt for a stock split just yet. At today’s level, a number of investors might find it accessible and attractive as they look at the long-term growth opportunity.
Should you buy stock in Moderna right now?
Before you buy stock in Moderna, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Moderna wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004… if you invested $1,000 at the time of our recommendation, you’d have $334,793!* Or when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $1,257,420!*
Now, it’s worth noting Stock Advisor’s total average return is 874% — a market-crushing outperformance compared to 209% for the S&P 500. Don’t miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
Adria Cimino has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Moderna. The Motley Fool has a disclosure policy.
For four years now, the stock market has been on a massive bull run. Since bottoming out in October 2022, the S&P 500 (^GSPC -1.82%) has soared, fueled in no small part by enormous gains in stocks connected to artificial intelligence (AI). But with stock valuations approaching very extreme levels, investors have good reason to
In Space Exploration Technologies‘ (SPCX -6.37%) recent third-quarter conference call, CEO Elon Musk was asked about the possibility of the company being merged with Tesla (TSLA -0.86%) — his other trillion-dollar company. Musk responded by saying he thought merging the two companies was a good idea and confirmed that each company had formed a special
The S&P 500 (SNPINDEX:^GSPC) has risen around 11% this year as I write. And by one valuation gauge with data going back to 1871, investors have rarely paid more for it. That gauge is the cyclically adjusted price-to-earnings ratio (CAPE ratio), popularized by Nobel Prize-winning economist Robert Shiller. Rather than a year of profits, it
Delayed 01:30:00 2026-11-02 am EST 5-day change 1st Jan Change 1,860.50 JPY -0.11% +0.32% -13.79% Published on 11/01/2026 at 11:06 pm EST MT Newswires This article is reserved for our members. Log in to continue Log inCreate an account 11:06pm Denso Revises Treasury Stock Disposal for Employee Incentive Plan After Partial Forfeiture MT Oct. 29
HONG KONG (AP) — Asian shares were mostly higher Monday but technology stocks remained volatile, while oil prices fell more than 3%. Japan’s Nikkei 225 gave up early gains, slipping 0.1% to 63,218.02 as some major technology names fell. Shares of OpenAI investor SoftBank Group dropped 1.8%. Japanese memory chipmaker Kioxia Holdings fell roughly 14%
ASML Holding (NasdaqGS:ASML) drew fresh attention after CEO Christophe Fouquet tied executive pay to a new Workplace Experience Index that tracks employee morale, following a year of restructuring and planned cuts of about 1,700 management roles. Recent trading has been choppy for ASML Holding, with the share price falling 6.6% in the last session and
The Market You know that old joke: you want the good news first or the bad news first? Here’s the good news: I think the action the last two days of the week last week in tech stocks (Nasdaq) changed quite a few minds. Here’s the bad news: I don’t have any actual data to
Stock futures opened higher Sunday evening as Wall Street prepares for a week packed with Apple earnings, the midterm elections and $100 oil. S&P 500 futures (ES=F), Nasdaq 100 futures (NQ=F) and Dow futures (YM=F) were all higher, with the tech-heavy Nasdaq leading the way after last week’s AI selloff. The selloff that closed out
The “Magnificent Seven” is a cohort of big tech stocks that consists of: Nvidia (NASDAQ: NVDA) Apple (NASDAQ: AAPL) Microsoft (NASDAQ: MSFT) Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) Amazon (NASDAQ: AMZN) Meta Platforms (NASDAQ: META) Tesla (NASDAQ: TSLA) This group of stocks have led the market for a long time, and they are among the top
Intel (INTC) stock fell 29% on Friday after guiding below estimates, erasing about $11 billion from the U.S. government’s stake. The hit lands on a holding President Donald Trump has publicly credited with making America billions. Intel closed Friday at $65.76, according to TradingView. However, at an average cost of $20.47 per share, the government’s
Mitsubishi Kakoki Kaisha just reported Q1 2027 earnings with a clean headline. Profitability over the last twelve months pushed net margin to 9.5%, and trailing earnings reached ¥8,322m. Yet the stock closed today at ¥2,698, down over the past month and quarter, as traders focused on the weaker recent share performance instead of the earnings
Mammoth Energy Services just dropped its Q3 2026 scorecard and the stock is already reacting. After the release, the shares closed at US$3.18, up 9.3% on the day, capping a strong short term run into the print. The headline is all about profitability, not revenue. Adjusted earnings before interest, tax, depreciation and amortization jumped to
Traders Holdings came into this earnings season looking like a value play that the market had lost interest in, with the share price down over the past week and month despite a P/E of 7x that trails both peers and the wider industry. Q1 2027 results put hard numbers behind that disconnect. Basic earnings per
Sumitomo Pharma closed today at ¥1,884.5 after a sharp multi month climb, with the stock up about 51% over the past quarter. The Q2 2027 earnings release just landed and the headline is simple. Profitability looks much thinner than the recent share price surge might suggest, with trailing net margin at 9.4% compared with 34.8%
The Vanguard S&P 500 ETF (NYSEMKT: VOO) has always been one of the best long-term investments for everyday, regular folks. But there are some legitimate questions about whether now is the right time to invest. Is it too top-heavy? Is it too concentrated in tech? Is it primed for a pullback given how far it’s
Micron (NASDAQ: MU) has had a fantastic year, with the stock up over 200%. The memory maker became the center of the next major bottleneck in artificial intelligence. As clusters of graphics processing units (GPUs) scaled to meet the needs of larger AI models, memory, which feeds data to the GPUs in various capacities, also
Copper underpins much of our energy infrastructure and is becoming increasingly important for data centers, where AI clusters and massive campuses require up to 10 times the electrical power of traditional cloud infrastructure. Because of its close ties to the power grid and data center hardware, copper stocks like Freeport-McMoRan (FCX -5.55%) have traded in
Quick Read RIVN beat earnings expectations with revenue up 38% to $2.16B, but still lost $913M and its stock remains down 42% this year. Rivian refused to break out R2 delivery numbers separately, raising transparency concerns while its pricier R1T and R1S models are presumed to be selling poorly. The US EV market shrank 30%
Richard Gray is an analyst who works for a foreign policy think tank in Washington, D.C. Since 2025, South Korea’s capital markets have vacillated from the world’s best-performing to shedding more than $1 trillion in market capitalization. This volatility is a story of how Korea’s financial system overlays supply chain specialization. With Korean firms Samsung
Coca-Cola (KO +1.36%) and UPS (UPS +0.86%) both recently reported encouraging third-quarter results. However, the market prices them very differently. UPS’ dividend currently yields over 6%, nearly triple Coke’s yield of more than 2%. That’s largely due to a big difference in their valuations. So which dividend stock is likelier to make you richer by
